Annovis Bio Inc.

NYS: ANVS

GO
/marketstate/country/us

Market open

 --Real time quotes

Feb 2, 2023, 9:52 a.m.

/zigman2/quotes/216213707/composite

$

18.79

Change

+0.74 +4.10%

Volume

Volume 7,023

Real time quotes

/zigman2/quotes/216213707/composite

Previous close

$ 18.05

$ 18.79

Change

+0.74 +4.10%

Day low

Day high

$18.04

$18.81

Open

52 week low

52 week high

$8.39

$23.91

Open

Annual Financials for Annovis Bio Inc.

Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Sales/Revenue -----
Cost of Goods Sold (COGS) incl. D&A -----
COGS excluding D&A -----
Depreciation & Amortization Expense -----
Depreciation -----
Amortization of Intangibles -----
Gross Income -----
20172018201920202021 5-year trend
SG&A Expense 682,433713,9371.61M6.64M14.54M
Research & Development 273,370111,608776,2563.05M8.48M
Other SG&A 409,063602,329829,3663.59M-
Other Operating Expense -----
Unusual Expense --79,50026,500-
EBIT after Unusual Expense --(1.69M)(6.67M)-
Non Operating Income/Expense -----
Non-Operating Interest Income 8466-47,22513,335
Equity in Affiliates (Pretax) -----
Interest Expense --40,933--
Gross Interest Expense --40,933--
Interest Capitalized -----
Pretax Income (682,349)(713,871)(990,980)(5.46M)(14.49M)
Income Tax -----
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (682,349)(713,871)(990,980)(5.46M)(14.49M)
Minority Interest Expense -----
Net Income (682,349)(713,871)(990,980)(5.46M)(14.49M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (682,349)(713,871)(990,980)(5.46M)(14.49M)
Preferred Dividends -----
Net Income Available to Common (682,349)(713,871)(990,980)(5.46M)(14.49M)
EPS (Basic) (0.10)(0.10)(0.14)(0.87)(1.90)
Basic Shares Outstanding 6.82M6.82M6.85M6.31M7.63M
EPS (Diluted) (0.10)(0.10)(0.14)(0.87)(1.90)
Diluted Shares Outstanding 6.82M6.82M6.85M6.31M7.63M
EBITDA (682,430)(713,940)(1.61M)(6.64M)(14.54M)
Link to MarketWatch's Slice.